Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème
0.3.0 - trial-use
Essais CLiniques Accessibles Interconnectés pour la Recherche ouverts à l'Ecosystème - Local Development build (v0.3.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
Draft as of 2024-02-26 |
<CodeSystem xmlns="http://hl7.org/fhir">
<id value="eclaire-study-phase-source-code-system"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p>This case-sensitive code system <code>https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">jarde-early<a name="eclaire-study-phase-source-code-system-jarde-early"> </a></td><td>Jardé phase précoce</td></tr><tr><td style="white-space:nowrap">phase-I-first-admin<a name="eclaire-study-phase-source-code-system-phase-I-first-admin"> </a></td><td>Human Pharmacology (Phase I) - First administration to humans</td></tr><tr><td style="white-space:nowrap">phase-I-bioequivalence<a name="eclaire-study-phase-source-code-system-phase-I-bioequivalence"> </a></td><td>Human Pharmacology (Phase I) - Bioequivalence Study</td></tr><tr><td style="white-space:nowrap">phase-I-other<a name="eclaire-study-phase-source-code-system-phase-I-other"> </a></td><td>Human Pharmacology (Phase I) - Other</td></tr><tr><td style="white-space:nowrap">phase-I-II-first-admin<a name="eclaire-study-phase-source-code-system-phase-I-II-first-admin"> </a></td><td>Phase I and Phase II (Integrated) - First administration to humans</td></tr><tr><td style="white-space:nowrap">phase-I-II-first-bioequivalence<a name="eclaire-study-phase-source-code-system-phase-I-II-first-bioequivalence"> </a></td><td>Phase I and Phase II (Integrated) - Bioequivalence Study</td></tr><tr><td style="white-space:nowrap">phase-I-II-other<a name="eclaire-study-phase-source-code-system-phase-I-II-other"> </a></td><td>Phase I and Phase II (Integrated) - Other</td></tr><tr><td style="white-space:nowrap">phase-II<a name="eclaire-study-phase-source-code-system-phase-II"> </a></td><td>Therapeutic exploratory (Phase II)</td></tr><tr><td style="white-space:nowrap">phase-II-III<a name="eclaire-study-phase-source-code-system-phase-II-III"> </a></td><td>Phase II and Phase III (Integrated)</td></tr><tr><td style="white-space:nowrap">phase-III<a name="eclaire-study-phase-source-code-system-phase-III"> </a></td><td>Therapeutic confirmatory (Phase III)</td></tr><tr><td style="white-space:nowrap">phase-IV<a name="eclaire-study-phase-source-code-system-phase-IV"> </a></td><td>Therapeutic use (Phase IV)</td></tr><tr><td style="white-space:nowrap">phase-III-IV<a name="eclaire-study-phase-source-code-system-phase-III-IV"> </a></td><td>Phase III and phase IV (Integrated)</td></tr></table></div>
</text>
<url
value="https://interop.esante.gouv.fr/ig/fhir/eclaire/CodeSystem/eclaire-study-phase-source-code-system"/>
<version value="0.3.0"/>
<name value="EclaireStudyPhaseSourceCS"/>
<title
value="Définition des phase de l'essai utilisés dans la base de données ECLAIRE"/>
<status value="draft"/>
<date value="2024-02-26T09:56:13+00:00"/>
<publisher value="ANS"/>
<contact>
<name value="ANS"/>
<telecom>
<system value="url"/>
<value value="https://esante.gouv.fr"/>
</telecom>
</contact>
<description
value="Définition des phases de l'essai utilisées dans la base de données ECLAIRE"/>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="FR"/>
<display value="FRANCE"/>
</coding>
</jurisdiction>
<caseSensitive value="true"/>
<content value="complete"/>
<count value="12"/>
<concept>
<code value="jarde-early"/>
<display value="Jardé phase précoce"/>
</concept>
<concept>
<code value="phase-I-first-admin"/>
<display
value="Human Pharmacology (Phase I) - First administration to humans"/>
</concept>
<concept>
<code value="phase-I-bioequivalence"/>
<display value="Human Pharmacology (Phase I) - Bioequivalence Study"/>
</concept>
<concept>
<code value="phase-I-other"/>
<display value="Human Pharmacology (Phase I) - Other"/>
</concept>
<concept>
<code value="phase-I-II-first-admin"/>
<display
value="Phase I and Phase II (Integrated) - First administration to humans"/>
</concept>
<concept>
<code value="phase-I-II-first-bioequivalence"/>
<display
value="Phase I and Phase II (Integrated) - Bioequivalence Study"/>
</concept>
<concept>
<code value="phase-I-II-other"/>
<display value="Phase I and Phase II (Integrated) - Other"/>
</concept>
<concept>
<code value="phase-II"/>
<display value="Therapeutic exploratory (Phase II)"/>
</concept>
<concept>
<code value="phase-II-III"/>
<display value="Phase II and Phase III (Integrated)"/>
</concept>
<concept>
<code value="phase-III"/>
<display value="Therapeutic confirmatory (Phase III)"/>
</concept>
<concept>
<code value="phase-IV"/>
<display value="Therapeutic use (Phase IV)"/>
</concept>
<concept>
<code value="phase-III-IV"/>
<display value="Phase III and phase IV (Integrated)"/>
</concept>
</CodeSystem>